文献
J-GLOBAL ID:201702219368358052
整理番号:17A1172513
低及び中間リスク前立腺癌に対する単独療法:早期毒性および生活結果品質の前立腺高線量率密封小線源治療13.5Gyの19Gyまたは2画分の一画分の無作為化第II相臨床試験【Powered by NICT】
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5Gy
著者 (13件):
Morton Gerard
(Sunnybrook Odette Cancer Centre, University of Toronto, Canada)
,
Chung Hans T.
(Sunnybrook Odette Cancer Centre, University of Toronto, Canada)
,
McGuffin Merrylee
(Sunnybrook Odette Cancer Centre, University of Toronto, Canada)
,
Helou Joelle
(Sunnybrook Odette Cancer Centre, University of Toronto, Canada)
,
D’Alimonte Laura
(Sunnybrook Odette Cancer Centre, University of Toronto, Canada)
,
Ravi Ananth
(Sunnybrook Odette Cancer Centre, University of Toronto, Canada)
,
Cheung Patrick
(Sunnybrook Odette Cancer Centre, University of Toronto, Canada)
,
Szumacher Ewa
(Sunnybrook Odette Cancer Centre, University of Toronto, Canada)
,
Liu Stanley
(Sunnybrook Odette Cancer Centre, University of Toronto, Canada)
,
Al-Hanaqta Motasem
(Sunnybrook Odette Cancer Centre, University of Toronto, Canada)
,
Zhang Liying
(Sunnybrook Odette Cancer Centre, University of Toronto, Canada)
,
Mamedov Alexandre
(Sunnybrook Odette Cancer Centre, University of Toronto, Canada)
,
Loblaw Andrew
(Sunnybrook Odette Cancer Centre, University of Toronto, Canada)
資料名:
Radiotherapy and Oncology
(Radiotherapy and Oncology)
巻:
122
号:
1
ページ:
87-92
発行年:
2017年
JST資料番号:
W3151A
ISSN:
0167-8140
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)